Table 6.
Disease | ncRNA | Evidence (PMID) |
---|---|---|
Breast Neoplasms |
H19 | 15985428;27540977;9811352;24780616 |
Breast Neoplasms |
PVT1 | 17908964;10485452;23907597 |
Breast Neoplasms |
SRA1 | 17710122;26460974 |
Breast Neoplasms |
WRAP53 | 27525856;15736456 |
Carcinoma, Hepatocellular | H19 | 9570364 |
Carcinoma, Hepatocellular | PCNA-AS1 | 24704293 |
Carcinoma, Hepatocellular | WRAP53 | 23836507 |
Lung Neoplasms |
HOTAIR | 25010625;22088988 |
Lung Neoplasms |
MALAT1 | 23243023;26490983 |
Lung Neoplasms |
PVT1 | 25400777 |
Lung Neoplasms |
XIST | 26339353 |
Prostatic Neoplasms | CDKN2B-AS1 | 27197191;24988946 |
Prostatic Neoplasms | H19 | 19513555;25895025 |
Prostatic Neoplasms | HOTAIR | 26411689 |
Prostatic Neoplasms | MALAT1 | 23845456 |
Prostatic Neoplasms | PCAT1 | 21804560 |
Prostatic Neoplasms | SRA1 | 16607388 |
Prostatic Neoplasms | XIST | 16261845 |
Stomach Neoplasms | CDKN2B-AS1 | 24810364;26187665 |
Stomach Neoplasms | HOTAIR | 25063030;23898077 |
Stomach Neoplasms | MALAT1 | 24857172 |
Urinary Bladder Neoplasms | H19 | 23354591 |
Urinary Bladder Neoplasms | WRAP53 | 27912092 |
The predicted ncRNAs related to lung cancer, liver cancer, breast cancer, urinary bladder neoplasms, prostatic neoplasms and stomach neoplasms based upon our method. Each research article reporting on a specific ncRNA is shown with a unique ID (PMID) by PubMed